Skip to main content
Log in

Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the added value of diffusion-weighted imaging (DWI) on MRI in differentiating serous from mucin-producing pancreatic cystic neoplasms (PCNs).

Methods

One hundred seventeen patients with PCN measuring ≥ 10 mm were included. Three readers independently evaluated MRI with and without the use of apparent diffusion coefficient (ADC). Logistic regression was used to analyze whether confidence scores were different with the use of different image sets. Diagnostic performance with and without ADC was compared.

Results

DWI/ADC improved confidence in 44.8%, 73.6%, and 78.2% of patients by the three readers in distinguishing serous from mucin-producing PCNs. The use of ADC increased the probability of a higher confidence in the differentiation as compared to morphological imaging for all three readers (p < 0.001). Odds ratio for increase in the diagnostic confidence with the use of ADC for the three readers with decreasing years of experience were 5.8, 6.8, and 12.7. The diagnostic accuracy of morphological MRI with ADC was higher than that without ADC for two of three readers with lesser experience (87.2% vs. 80.8%; 91.5% vs. 80.8%).

Conclusion

DWI may have added value as a complementary tool to conventional morphological MRI in differentiating between serous and mucin-producing PCNs with possibly greater value for readers with less experience in reading abdominal MRI.

Key Points

Optimal management of PCNs requires differentiation of serous from mucin-producing PCNs.

ADC measurements allow increased confidence in differentiating serous from mucin-producing PCNs.

ADC measurements increase the accuracy in diagnosing serous versus mucin-producing PCNs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

BD-IPMN:

Branch duct intraductal papillary mucinous neoplasm

CE-MRI:

Contrast-enhanced magnetic resonance imaging

CT:

Computed tomography

DWI:

Diffusion-weighted imaging

FNA:

Fine needle aspiration

FS:

Fat saturation

GRE:

Gradient echo

IPMN:

Intraductal papillary mucinous neoplasm

MCN:

Mucinous cystic neoplasm

MD-IPMN:

Main duct intraductal papillary mucinous neoplasm

MRCP:

Magnetic resonance cholangiopancreatography

MRI:

Magnetic resonance imaging

PCN:

Pancreatic cystic neoplasm

SCA:

Serous cystadenoma

SD:

Standard deviation

References

  1. Zhang XP, Yu ZX, Zhao YP, Dai MH (2016) Current perspectives on pancreatic serous cystic neoplasms: diagnosis, management and beyond. World J Gastrointest Surg 8:202–211

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sahani DV, Kambadakone A, Macari M, Takahashi N, Chari S, Fernández-del Castillo C (2013) Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol 200:343–354

    Article  PubMed  Google Scholar 

  3. Lennon AM, Manos LL, Hruban RH et al (2014) Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol 21:3668–3674

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tanaka M, Fernández-del Castillo C, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197

    Article  Google Scholar 

  5. Song SJ, Lee JM, Kim YJ et al (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86–93

    Article  PubMed  Google Scholar 

  6. Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR (2008) Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 27:1448–1454

    Article  PubMed  Google Scholar 

  7. Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV (2007) Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol 189:648–656

    Article  PubMed  Google Scholar 

  8. Do RK, Katz SS, Gollub MJ et al (2014) Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol 203:973–979

    Article  PubMed  PubMed Central  Google Scholar 

  9. Choi JY, Kim MJ, Lee JY et al (2009) Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation. AJR Am J Roentgenol 193:136–142

    Article  PubMed  Google Scholar 

  10. Sun HY, Kim SH, Kim MA, Lee JY, Han JK, Choi BI (2010) CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification. Eur J Radiol 75:e45–e55

    Article  PubMed  Google Scholar 

  11. de Jong K, Nio CY, Hermans JJ et al (2010) High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 8:806–811

    Article  PubMed  Google Scholar 

  12. Megibow AJ, Baker ME, Morgan DE et al (2017) Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. https://doi.org/10.1016/j.jacr.2017.03.010

  13. Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernández-Del Castillo C (2010) Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 10:144–150

    Article  PubMed  PubMed Central  Google Scholar 

  14. Valsangkar NP, Morales-Oyarvide V, Thayer SP et al (2012) 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 152:S4–S12

    Article  PubMed  PubMed Central  Google Scholar 

  15. Schraibman V, Goldman SM, Ardengh JC et al (2011) New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study. Pancreatology 11:43–51

    Article  PubMed  Google Scholar 

  16. Le Bihan D, Turner R, Douek P, Patronas N (1992) Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 159:591–599

    Article  PubMed  Google Scholar 

  17. Pozzessere C, Castaños Gutiérrez SL, Corona-Villalobos CP et al (2016) Diffusion-weighted magnetic resonance imaging in distinguishing between mucin-producing and serous pancreatic cysts. J Comput Assist Tomogr 40:505–512

    Article  PubMed  PubMed Central  Google Scholar 

  18. Sandrasegaran K, Akisik FM, Patel AA et al (2011) Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol 66:808–814

    Article  CAS  PubMed  Google Scholar 

  19. Cicchetti DV (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290

  20. Boraschi P, Donati F, Gigoni R, Salemi S, Bartolozzi C, Falaschi F (2010) Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Magn Reson Imaging 28:1447–1455

    Article  PubMed  Google Scholar 

  21. Fatima Z, Ichikawa T, Motosugi U et al (2011) Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cystic lesions. Clin Radiol 66:108–111

    Article  CAS  PubMed  Google Scholar 

  22. Irie H, Honda H, Kuroiwa T et al (2002) Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging. Abdom Imaging 27:82–87

    Article  CAS  PubMed  Google Scholar 

  23. Mottola JC, Sahni VA, Erturk SM, Swanson R, Banks PA, Mortele KJ (2012) Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-tesla: preliminary results. Abdom Imaging 37:110–117

    Article  PubMed  Google Scholar 

  24. Yamashita Y, Namimoto T, Mitsuzaki K et al (1998) Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology 208:605–609

    Article  CAS  PubMed  Google Scholar 

  25. Khashab MA, Kim K, Lennon AM et al (2013) Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas 42:717–721

    Article  PubMed  Google Scholar 

  26. Ngamruengphong S, Lennon AM (2016) Analysis of pancreatic cyst fluid. Surg Pathol Clin 9:677–684

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sasaki M, Yamada K, Watanabe Y et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249:624–630

    Article  PubMed  Google Scholar 

  28. Barral M, Sebbag-Sfez D, Hoeffel C et al (2013) Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-tesla: preliminary experience. Diagn Interv Imaging 94:619–627

    Article  CAS  PubMed  Google Scholar 

  29. Do RK, Chandarana H, Felker E et al (2010) Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 195:671–676

    Article  PubMed  Google Scholar 

  30. Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ye XH, Gao JY, Yang ZH, Liu Y (2014) Apparent diffusion coefficient reproducibility of the pancreas measured at different MR scanners using diffusion-weighted imaging. J Magn Reson Imaging 40:1375–1381

    Article  Google Scholar 

  32. Pandey A, Pandey P, Ghasabeh MA et al (2018) Accuracy of apparent diffusion coefficient in differentiating pancreatic neuroendocrine tumour from intrapancreatic accessory spleen. Eur Radiol 28:1560–1567

    Article  PubMed  Google Scholar 

  33. European Study Group on Cystic Tumours of the Pancreas (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67:789–804

    Article  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ihab R. Kamel.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Ihab R. Kamel.

Conflict of interest

The authors declare that they have no conflict of interest.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the institutional review board.

Ethical approval

Institutional review board approval was obtained.

Methodology

• retrospective

• diagnostic study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 667 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pandey, P., Pandey, A., Shao, N. et al. Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms. Eur Radiol 29, 4660–4669 (2019). https://doi.org/10.1007/s00330-019-6010-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-019-6010-9

Keywords

Navigation